Kontour Medical Technology Stock Net Income
| 688314 Stock | 28.62 0.38 1.35% |
Kontour Medical Technology fundamentals help investors to digest information that contributes to Kontour Medical's financial success or failures. It also enables traders to predict the movement of Kontour Stock. The fundamental analysis module provides a way to measure Kontour Medical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Kontour Medical stock.
| Last Reported | Projected for Next Year | ||
| Net Income From Continuing Ops | 74.5 M | 73 M | |
| Net Income | 75.5 M | 74.2 M |
Kontour | Net Income |
Kontour Medical Technology Company Net Income Analysis
Kontour Medical's Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Kontour Medical Net Income | 75.51 M |
Most of Kontour Medical's fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Kontour Medical Technology is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Kontour Net Interest Income
Net Interest Income |
|
Based on the recorded statements, Kontour Medical Technology reported net income of 75.51 M. This is 77.87% lower than that of the Health Care Equipment & Supplies sector and significantly higher than that of the Health Care industry. The net income for all China stocks is 86.78% higher than that of the company.
Kontour Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Kontour Medical's direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Kontour Medical could also be used in its relative valuation, which is a method of valuing Kontour Medical by comparing valuation metrics of similar companies.Kontour Medical is currently under evaluation in net income category among its peers.
Kontour Fundamentals
| Current Valuation | 2 B | ||||
| Price To Book | 3.66 X | ||||
| Price To Sales | 7.59 X | ||||
| Revenue | 275.03 M | ||||
| EBITDA | 106.76 M | ||||
| Net Income | 75.51 M | ||||
| Total Debt | 37.97 M | ||||
| Cash Flow From Operations | 85.22 M | ||||
| Total Asset | 675.79 M | ||||
| Retained Earnings | 164.9 M | ||||
| Working Capital | 346.95 M | ||||
| Annual Yield | 0.01 % | ||||
| Net Asset | 675.79 M |
About Kontour Medical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Kontour Medical Technology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Kontour Medical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Kontour Medical Technology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Currently Active Assets on Macroaxis
Other Information on Investing in Kontour Stock
Kontour Medical financial ratios help investors to determine whether Kontour Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Kontour with respect to the benefits of owning Kontour Medical security.